Efficacy of ciprofloxacin in an experimental model of escherichia coli chorioamnionitis in rabbits

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1624-1627

  Launay, Elise ^a   Joram, Nicolas ^a   Jacqueline, Cédric ^b   Francoise Miegeville, Anne ^b   Caillon, Jocelyne ^b,c   Potel, Gilles ^b   Christophe Roze, Jean ^a   Gras Le Guen, Christele ^a,b  

^a Hopital Mere Enfant CHU de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GENTAMICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CHORIOAMNIONITIS; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FEMALE; FETUS; MUTANT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SURVIVAL RATE;

ANIMALS; ANTI-INFECTIVE AGENTS; CHORIOAMNIONITIS; CIPROFLOXACIN; ESCHERICHIA COLI INFECTIONS; FEMALE; FETUS; PREGNANCY; RABBITS;

EID: 65649133993     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00186-08     Document Type: Article

References (18)

1. Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
2. Bracci, R., and G. Buonocore. 2003. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol. Neonate 83:85-96. (Pubitemid 36184381)
3. Bryant, R. E., and J. A. Mazza. 1989. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am. J. Med. 87:27S-33S. (Pubitemid 20005137)
4. Bufjk, S. E., J. W. Mouton, I. C. Gyssens, H. A. Verbrugh, and H. A. Bruining. 2002. Experience with a once-daily dosing program of aminogly-cosides in critically ill patients. Intensive Care Med. 28:936-942. (Pubitemid 34762230)
5. Campoli-Richards, D. M., J. P. Monk, A. Price, P. Benfleld, P. A. Todd, and A. Ward. 1988. Ciprofloxacin. A review of its bactericidal activity, pharma-cokinetic properties and therapeutic use. Drugs 35:373-447. (Pubitemid 18103339)
6. Debillon, T., C. Gras-Le Guen, V. Venelle, N. Winer, J. Caillon, J. C. Rozé, and P. Gressens. 2000. Intra-uterine infection induces programmed cell death in rabbit white matter. Pediatr. Res. 47:736-742. (Pubitemid 30365431)
7. Firsov, A., S. Vostrov, O. Kononenko, S. Zinner, and Y. Portnoy. 1999. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Esche-richia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 43:498-502. (Pubitemid 29109509)
8. Forrest, A., D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham, and J. J. Schentag. 1993. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37:1073-1081. (Pubitemid 23141323)
9. Gibbs, R. S. 2004. Management of clinical chorioamnionitis at term. Am. J. Obstet. Gynecol. 191:1-2. (Pubitemid 39077947)
10. Gibbs, R S. 2001. The relationship between infections and adverse preg-nancy outcomes: an overview. Ann. Periodontol. 6:153-163.
11. Gras-Le Guen, C., T. Debillon, C. Toquet, A. Jarry, N. Winer, C. Jacqueline, M.F. Kergueris, E. Bingen, P.C. Roźe, G. Bugnon. 2003. Persistent bacteremia in rabbit fetuses despite maternal antibiotic therapy in a novel intrauterine-infection model. Antimicrob. Agents Chemother. 47:2125-2130. (Pubitemid 36753561)
12. Hopkins, L., and F. Smaill. 2002. Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst. Rev. 3:CD003254.
13. Lorian, V. 1991. Laboratory methods used to assess the activity of antimi-crobial combinations, p. 434-444. In V. Lorian (ed.), Antibiotics in labora-tory medicine, 3rd ed. The Williams and Wilkins Co., Baltimore, MD.
14. Nichol, K. L., L. R. Peterson, C. E. Fasching, and D. N. Gerding. 1984. Ciprofloxacin penetration into extravascular spaces in a rabbit model. Anti-microb. Agents Chemother. 26:935-936. (Pubitemid 15181395)
15. Putnam, S. D., J. W. Sanders, D. R. Tribble, D. R. Rockabrand, M. S. Riddle, P. J. Rozmajzl, and R. W. Frenck. 2005. Fosttreatment changes in Esche-richia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin. Antimicrob. Agents Chemother. 49:2571-2572. (Pubitemid 40734510)
16. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. FÍuoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88. (Pubitemid 43050081)
17. Speer, C. P. 2003. Inflammation and bronchopulmonary dysplasia. Semin. Neonato!. 8:29-38. (Pubitemid 36356491)
18. Xiong, Y. Q., G. Potel, J. Caillon, G. Stephant, F. Jehl, D. Bugnon, P. Le Conte, D. Baron, and H. Drageon. 1995. Comparative efficacies of cipro-floxacin and Pefloxacin alone or in combination with fosfomycin in experi-mental endocarditis induced by multidrug-susceptible and -resistant Pseudo-monas aeruginosa. Antimicrob. Agents Chemother. 39:496-499.